ONeil Trader is an independent analyst and Seeking Alpha Marketplace contributor who focuses on small/mid cap and biotech stocks. What to look for in biotechs, why growth and biotechs often trade at a ...

E. Roudasev is a senior business manager for a major financial institution. Her areas of interest are biotech, environmental tech and credit risks. The opportunities in under the radar biotechs, ...

PDS Biotech is a late-stage immunotherapy company preparing to initiate a Phase 3 clinical trial evaluating Versamune HPV + pembrolizumab as a potential first-line treatment for recurrent or ...

WOODLAND HILLS, CA / ACCESSWIRE / August 12, 2024 / BioTech Medics, Inc. (OTC PINK:BMCS) is pleased to announce that the company's CEO sat down for an interview with The Beast of Wall Street on August ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

All industries, including biotechnology, are faced with a drastically different economic environment from that of four or five years ago. To get a sense of how a key biotech supplier that operates on ...

The long winter for biotech stocks is over. Shares have climbed to levels not seen since late 2021, buoyed by eye-popping takeover valuations, trailblazing innovation in battling obesity and cancer, ...

FLORHAM PARK, N.J., May 12, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease ...

Lux Capital is advising its biotech startups to focus on three qualities as the public-market pullback threatens to hit private companies. After record years for launching startups, raising capital, ...

For a biotech executive hoping to make something vast, Chris Gibson seems proudest in obsessing over the tiniest details. Gibson is the CEO of Recursion Pharmaceuticals, a biotech upstart aiming to ...

New Taipei City, Taiwan, May 29, 2026 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the “Company” or “Jyong Biotech”), a science-driven biotechnology company dedicated to the development and ...